PROVIDER PROFILE · NPI 1750478848

Felice Schnoll-SussmanMD

GastroenterologyNew York, NYI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

355

Unique beneficiaries

—

Total services

383

Distinct HCPCS

Medicare payment

$42K

Peer benchmark

Total Medicare services vs. 1,360 Gastroenterology providers in NY — below median (cohort median 521).

PRESCRIBING · PART D · 2024

Total Rx claims

Beneficiaries

—

Total drug cost

$20K

Distinct drugs

Brand share

64.7%

Top prescribed drugs

Omeprazole12 claims

Dexlansoprazole11 claims

Linaclotide11 claims

QUALITY · MIPS · 2024

Final MIPS score

100.0

Quality

85.3

Cost

0.0

Improvement activities

40.0

Promoting interop.

100.0

Payment adjustment

1.05%

APM Entity

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$14K

Payment records

By payment type

Honoraria$7K

Consulting Fee$3K

Travel and Lodging$3K

Food and Beverage$1K

REFERRAL NETWORK

Where Felice Schnoll-Sussman's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 6 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
CENTER FOR SPECIALTY CARE INC	36	41
Frederick Axelrod Anesthesiology · New York, NY	24	29
Cohen Dermatopathology, P.C. Clinical Laboratory · Needham, MA	23	25
Jose Jessurun-Solomou Pathology · New York, NY	18	35
Peter Okin Cardiology · New York, NY	11	22
Nicole Panarelli Pathology · New York, NY	11	22

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history